SE9702305D0 - New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives - Google Patents

New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives

Info

Publication number
SE9702305D0
SE9702305D0 SE9702305A SE9702305A SE9702305D0 SE 9702305 D0 SE9702305 D0 SE 9702305D0 SE 9702305 A SE9702305 A SE 9702305A SE 9702305 A SE9702305 A SE 9702305A SE 9702305 D0 SE9702305 D0 SE 9702305D0
Authority
SE
Sweden
Prior art keywords
oxazolidinedione
oxadiazolidinedione
derivatives
thiazolidinedione
new thiazolidinedione
Prior art date
Application number
SE9702305A
Other languages
English (en)
Swedish (sv)
Inventor
Kjell Andersson
Maria Boije
Lanna Li
Eva-Lotte Lindstedt
Bengt Ljung
Bo Norden
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9702305A priority Critical patent/SE9702305D0/xx
Publication of SE9702305D0 publication Critical patent/SE9702305D0/xx
Priority to ZA984795A priority patent/ZA984795B/xx
Priority to EP98928757A priority patent/EP0991632A1/fr
Priority to NZ501428A priority patent/NZ501428A/en
Priority to CA002293449A priority patent/CA2293449A1/fr
Priority to PCT/SE1998/001066 priority patent/WO1998057941A1/fr
Priority to JP50425699A priority patent/JP2002503255A/ja
Priority to AU80475/98A priority patent/AU732105B2/en
Priority to US09/091,875 priority patent/US6288096B1/en
Priority to ARP980102644A priority patent/AR012924A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE9702305A 1997-06-17 1997-06-17 New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives SE9702305D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE9702305A SE9702305D0 (sv) 1997-06-17 1997-06-17 New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
ZA984795A ZA984795B (en) 1997-06-17 1998-06-03 New thiazolidinedione oxazolidinedione and oxadiazolidinedione derivatives
EP98928757A EP0991632A1 (fr) 1997-06-17 1998-06-04 Nouveaux thiazolidinediones, oxazolidinediones et derives d'oxazolidinediones
NZ501428A NZ501428A (en) 1997-06-17 1998-06-04 Thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives useful for conditions such as insulin resistance
CA002293449A CA2293449A1 (fr) 1997-06-17 1998-06-04 Nouveaux thiazolidinediones, oxazolidinediones et derives d'oxazolidinediones
PCT/SE1998/001066 WO1998057941A1 (fr) 1997-06-17 1998-06-04 Nouveaux thiazolidinediones, oxazolidinediones et derives d'oxazolidinediones
JP50425699A JP2002503255A (ja) 1997-06-17 1998-06-04 新しいチアゾリジンジオン、オキサゾリジンジオンおよびオキサジアゾリジンジオン誘導体
AU80475/98A AU732105B2 (en) 1997-06-17 1998-06-04 New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
US09/091,875 US6288096B1 (en) 1997-06-17 1998-06-04 Thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
ARP980102644A AR012924A1 (es) 1997-06-17 1998-06-04 Derivados de tiazolidindiona, oxazolidindiona y oxadiazolidindiona, proceso para su preparacion, composiciones y formulaciones farmaceuticas, usode dichos compuestos para la fabricacion de formulaciones y metodo de tratamiento

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702305A SE9702305D0 (sv) 1997-06-17 1997-06-17 New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives

Publications (1)

Publication Number Publication Date
SE9702305D0 true SE9702305D0 (sv) 1997-06-17

Family

ID=20407407

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702305A SE9702305D0 (sv) 1997-06-17 1997-06-17 New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives

Country Status (10)

Country Link
US (1) US6288096B1 (fr)
EP (1) EP0991632A1 (fr)
JP (1) JP2002503255A (fr)
AR (1) AR012924A1 (fr)
AU (1) AU732105B2 (fr)
CA (1) CA2293449A1 (fr)
NZ (1) NZ501428A (fr)
SE (1) SE9702305D0 (fr)
WO (1) WO1998057941A1 (fr)
ZA (1) ZA984795B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801990D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
JP2007502847A (ja) * 2003-05-13 2007-02-15 シントン・ベスローテン・フェンノートシャップ チアゾリジンジオン誘導体およびその化合物を製造する方法
US7230016B2 (en) * 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
WO2005080387A2 (fr) * 2004-02-20 2005-09-01 Synthon B.V. Procedes pour produire de la pioglitazone et composes issus de ces procedes
US7161756B2 (en) * 2004-05-10 2007-01-09 Tandberg Data Storage Asa Method and system for communication between a tape drive and an external device
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
WO2006138328A1 (fr) * 2005-06-14 2006-12-28 Merck & Co., Inc. Procede de production d'oxazolidinediones anti-diabetiques
TW200815377A (en) * 2006-04-24 2008-04-01 Astellas Pharma Inc Oxadiazolidinedione compound
US20160331729A9 (en) 2007-04-11 2016-11-17 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
NZ580963A (en) 2007-04-11 2012-08-31 Omeros Corp Compositions and methods for prophylaxis and treatment of addictions
US11241420B2 (en) 2007-04-11 2022-02-08 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
CA2796872A1 (fr) * 2010-04-19 2011-10-27 Metabolic Solutions Development Company, Llc Nouvelle synthese pour des composes de thiazolidinedione
KR101781665B1 (ko) 2010-04-19 2017-09-25 씨리우스 테라퓨틱스, 엘엘씨 티아졸리딘디온 화합물을 위한 신규한 합성법
AU2011289627B2 (en) 2010-08-10 2015-01-15 Metabolic Solutions Development Company, Llc Synthesis for thiazolidinedione compounds
PL2603498T3 (pl) 2010-08-10 2017-06-30 Octeta Therapeutics, Llc Nowa synteza związków tiazolidynodionu
AU2011326872C1 (en) 2010-11-08 2015-02-19 Albireo Ab A pharmaceutical combination comprising an IBAT inhibitor and a bile acid binder
US20130225511A1 (en) 2010-11-08 2013-08-29 Per-Göran Gillberg Ibat inhibitors for the treatment of liver diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US5223522A (en) * 1988-03-08 1993-06-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents

Also Published As

Publication number Publication date
ZA984795B (en) 1999-01-04
CA2293449A1 (fr) 1998-12-23
AR012924A1 (es) 2000-11-22
AU8047598A (en) 1999-01-04
AU732105B2 (en) 2001-04-12
NZ501428A (en) 2001-05-25
JP2002503255A (ja) 2002-01-29
WO1998057941A1 (fr) 1998-12-23
US6288096B1 (en) 2001-09-11
EP0991632A1 (fr) 2000-04-12

Similar Documents

Publication Publication Date Title
SE9801992D0 (sv) New 3-aryl-2-hydroxypropionic acid derivative I
SE9702305D0 (sv) New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
MY129581A (en) New 3-aryl propionic acid derivatives and analogs
ATE109145T1 (de) Heterozyklische acylaminothiazolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
NO303782B1 (no) Tiazolidin- og oksazolidinderivater og farmas°ytiske preparater inneholdende slike, samt deres anvendelse til fremstilling av medikamenter
FI873162A (fi) Foerfarande foer framstaellning av proteiner med faktor viii aktivitet med mikrobiala vaerdceller; expressionsvektorer, vaerdceller och antikroppar.
DE3750431D1 (de) Stabilisiertes Arzneimittel und dessen Herstellung.
TR199901361T2 (xx) S�lfonamid t�revleri, haz�rlanma prosesi ve ila� olarak kullan�mlar�
ZA975866B (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
FI943579A (fi) Bentsokondensoituja 5-rengasheterosyklejä, menetelmä niiden valmistamiseksi, niiden käyttö lääkkeinä, niiden käyttö diagnostisina aineina sekä niitä sisältävät lääkkeet
AU5799294A (en) Isoxazole-4-carboxamides and hydroxy-alkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
NO20002835L (no) 2-aryl-oksodihydropurinderivater, fremgangsmÕte for fremstilling av disse medisinske preparater inneholdende disse, og mellomprodukter derfor
DE69931925D1 (de) 2-chinolonen enthaltende arzneimittel
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
DE3580616D1 (de) Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE297935T1 (de) 2-(iminomethyl)aminophenyl-derivate, deren herstellung, verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen
DE69815094D1 (de) 2-(iminoethyl)-aminophenyl - derivate, deren herstellung, deren verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen
DE3877406T2 (de) Benzothiazolinon-derivate, ihre herstellung und pharmazeutische zusammensetzung.
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
HK1040249A1 (en) Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical composition containing said compounds and the use thereof.
AU6242190A (en) New thiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
DE59811437D1 (de) Oxiranyl-triazolinthione und ihre verwendung als mikrobizide
AU4246489A (en) New benzoxazolinone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
IT7925706A0 (it) Uso di glicerilfosforilderivati nella terapia di dislipemie ed epatiti, e composizioni farmaceutiche relative.
DE3685743T2 (de) Anthracyclinderivate, ihre verwendung als antitumorsubstanzen und ihre herstellung.